Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2025 ▲▼ | Q4 2025 ▲▼ | Change ▲▼ | Q3 2025 ▲▼ | Q4 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| KLA Corporation(KLAC) | 21,883 | 21,883 | 0 | $23.60M | $26.59M | 15.57% | +$2.99M |
| Bristol-Myers Squibb Company(BMY) | 316,842 | 302,842 | -14,000 | $14.29M | $16.34M | 9.56% | +$2.05M |
| Compass Therapeutics, Inc.(CMPX) | 872,938 | 1,592,938 | +720,000 | $3.06M | $8.55M | 5.01% | +$5.50M |
| Stoke Therapeutics, Inc.(STOK) | 210,000 | 260,000 | +50,000 | $4.93M | $8.25M | 4.83% | +$3.32M |
| Lam Research Corporation(LRCX) | 0 | 40,329 | +40,329 | $0 | $6.90M | 4.04% | +$6.90M |
| Olema Pharmaceuticals, Inc.(OLMA) | 174,000 | 269,000 | +95,000 | $1.70M | $6.72M | 3.94% | +$5.02M |
| Structure Therapeutics IncADR | 78,000 | 90,000 | +12,000 | $2.18M | $6.26M | 3.66% | +$4.08M |
| Protagonist Therapeutics Inc | 48,000 | 55,000 | +7,000 | $3.19M | $4.80M | 2.81% | +$1.62M |
| Acadia Pharmaceuticals Inc | 171,000 | 171,000 | 0 | $3.65M | $4.57M | 2.67% | +$918.3K |
| Ovintiv Inc.(OVV) | 107,500 | 107,500 | 0 | $4.34M | $4.21M | 2.47% | -$127.9K |
| Prothena Corp PlcSHS SHS | 549,019 | 441,019 | -108,000 | $5.36M | $4.21M | 2.47% | -$1.15M |
| Solid Biosciences Inc | 296,955 | 705,955 | +409,000 | $1.83M | $3.98M | 2.33% | +$2.15M |
| Neurocrine Biosciences, Inc.(NBIX) | 28,690 | 27,190 | -1,500 | $4.03M | $3.86M | 2.26% | -$171.1K |
| Amicus Therapeutics Inc COM | 253,000 | 253,000 | 0 | $1.99M | $3.60M | 2.11% | +$1.61M |
| Bicycle Therapeutics PlcADS | 154,000 | 462,700 | +308,700 | $1.19M | $3.28M | 1.92% | +$2.08M |
| Phathom Pharmaceuticals, Inc.(PHAT) | 85,000 | 195,000 | +110,000 | $1.00M | $3.24M | 1.89% | +$2.23M |
| Castle Biosciences, Inc.(CSTL) | 110,600 | 80,600 | -30,000 | $2.52M | $3.14M | 1.84% | +$617.0K |
| Intellia Therapeutics, Inc.(NTLA) | 60,000 | 315,400 | +255,400 | $1.04M | $2.84M | 1.66% | +$1.80M |
| Immunome, Inc.(IMNM) | 105,000 | 130,000 | +25,000 | $1.23M | $2.79M | 1.63% | +$1.56M |
| Corcept Therapeutics Incorporated(CORT) | 67,200 | 67,200 | 0 | $5.58M | $2.34M | 1.37% | -$3.25M |
| Vera Therapeutics, Inc.CL A(VERA) | 0 | 44,000 | +44,000 | $0 | $2.23M | 1.30% | +$2.23M |
| Quidelortho Corp | 72,548 | 72,548 | 0 | $2.14M | $2.07M | 1.21% | -$64.6K |
| NovoCure Limited(NVCR) | 102,100 | 152,100 | +50,000 | $1.32M | $1.97M | 1.15% | +$647.5K |
| Biodesix, Inc.(BDSX) | 286,804 | 286,804 | 0 | $2.17M | $1.95M | 1.14% | -$215.1K |
| Cytokinetics, Incorporated(CYTK) | 30,000 | 30,000 | 0 | $1.65M | $1.91M | 1.12% | +$257.4K |
| Phreesia, Inc.(PHR) | 114,700 | 110,700 | -4,000 | $2.70M | $1.87M | 1.10% | -$824.7K |
| EQT Corporation(EQT) | 34,619 | 34,619 | 0 | $1.88M | $1.86M | 1.09% | -$28.7K |
| Harrow, Inc.(HROW) | 40,000 | 34,000 | -6,000 | $1.93M | $1.67M | 0.98% | -$261.2K |
| Travere Therapeutics, Inc.(TVTX) | 43,060 | 43,000 | -60 | $1.03M | $1.64M | 0.96% | +$613.9K |
| Foghorn Therapeutics Inc.(FHTX) | 281,730 | 281,730 | 0 | $1.38M | $1.52M | 0.89% | +$143.7K |
| United Therapeutics Corporation(UTHR) | 3,000 | 3,000 | 0 | $1.26M | $1.46M | 0.86% | +$204.1K |
| Ultragenyx Pharmaceutical Inc.(RARE) | 22,000 | 62,000 | +40,000 | $661.8K | $1.43M | 0.83% | +$764.2K |
| Alkermes plcSHS(ALKS) | 50,000 | 50,000 | 0 | $1.50M | $1.40M | 0.82% | -$101.0K |
| Nektar Therapeutics(NKTR) | 4,021 | 31,000 | +26,979 | $228.8K | $1.31M | 0.77% | +$1.08M |
| Apogee Therapeutics Inc | 16,000 | 16,000 | 0 | $635.7K | $1.21M | 0.71% | +$572.0K |
| Verastem, Inc.(VSTM) | 0 | 150,000 | +150,000 | $0 | $1.16M | 0.68% | +$1.16M |
| Axsome Therapeutics, Inc.(AXSM) | 6,000 | 6,061 | +61 | $728.7K | $1.11M | 0.65% | +$378.3K |
| Masimo Corp | 8,280 | 8,280 | 0 | $1.22M | $1.08M | 0.63% | -$144.8K |
| 10x Genomics, Inc.(TXG) | 0 | 59,000 | +59,000 | $0 | $962.3K | 0.56% | +$962.3K |
| Xenon Pharmaceuticals Inc.(XENE) | 21,000 | 21,000 | 0 | $843.1K | $941.2K | 0.55% | +$98.1K |
| Pacific Biosciences of California, Inc.(PACB) | 500,000 | 500,000 | 0 | $640.0K | $935.0K | 0.55% | +$295.0K |
| Kalvista Pharmaceuticals Inc | 67,000 | 57,000 | -10,000 | $816.1K | $920.5K | 0.54% | +$104.5K |
| Freeport-McMoRan Inc.CL B(FCX) | 18,044 | 18,046 | +2 | $707.7K | $916.6K | 0.54% | +$208.9K |
| Ventyx Biosciences Inc | 98,827 | 100,827 | +2,000 | $307.4K | $910.5K | 0.53% | +$603.1K |
| Pharvaris N V COM | 14,847 | 29,847 | +15,000 | $370.4K | $828.3K | 0.48% | +$457.8K |
| Illumina, Inc.(ILMN) | 0 | 6,000 | +6,000 | $0 | $787.0K | 0.46% | +$787.0K |
| uniQure N.V.SHS(QURE) | 78,728 | 30,789 | -47,939 | $4.60M | $736.8K | 0.43% | -$3.86M |
| Halozyme Therapeutics, Inc.(HALO) | 10,100 | 10,100 | 0 | $740.7K | $679.7K | 0.40% | -$61.0K |
| Biohaven Ltd | 0 | 59,365 | +59,365 | $0 | $670.2K | 0.39% | +$670.2K |
| BridgeBio Pharma, Inc.(BBIO) | 8,688 | 8,688 | 0 | $451.3K | $664.5K | 0.39% | +$213.3K |
| Treace Medical Concepts, Inc.(TMCI) | 176,947 | 226,947 | +50,000 | $1.19M | $556.0K | 0.33% | -$631.3K |
| Pulmonx Corporation(LUNG) | 0 | 250,573 | +250,573 | $0 | $553.8K | 0.32% | +$553.8K |
| Rapt Therapeutics Inc | 0 | 15,000 | +15,000 | $0 | $508.1K | 0.30% | +$508.1K |
| Gossamer Bio, Inc.(GOSS) | 138,176 | 138,176 | 0 | $363.4K | $428.3K | 0.25% | +$64.9K |
| Alphatec Holdings, Inc.(ATEC) | 33,000 | 18,058 | -14,942 | $479.8K | $379.9K | 0.22% | -$99.9K |
| Outset Medical, Inc.(OM) | 78,584 | 98,913 | +20,329 | $1.11M | $367.0K | 0.21% | -$742.6K |
| Apellis Pharmaceuticals Inc COM | 14,000 | 14,000 | 0 | $316.8K | $351.7K | 0.21% | +$34.9K |
| Liquidia Corporation(LQDA) | 0 | 10,000 | +10,000 | $0 | $344.9K | 0.20% | +$344.9K |
| Candel Therapeutics, Inc.(CADL) | 60,000 | 60,000 | 0 | $306.0K | $339.0K | 0.20% | +$33.0K |
| Voyager Therapeutics, Inc.(VYGR) | 134,918 | 74,918 | -60,000 | $630.1K | $294.4K | 0.17% | -$335.6K |
| Trinity Capital Inc.(TRIN) | 0 | 20,000 | +20,000 | $0 | $293.0K | 0.17% | +$293.0K |
| Inhibrx Biosciences, Inc.(INBX) | 31,698 | 3,698 | -28,000 | $1.07M | $292.1K | 0.17% | -$775.4K |
| Kayne Anderson BDC, Inc.(KBDC) | 0 | 20,000 | +20,000 | $0 | $286.4K | 0.17% | +$286.4K |
| Cullinan Therapeutics, Inc.(CGEM) | 20,000 | 20,000 | 0 | $118.6K | $207.0K | 0.12% | +$88.4K |
| Elutia Inc.(ELUT) | 711,175 | 263,018 | -448,157 | $633.1K | $182.2K | 0.11% | -$450.9K |
| Alumis Inc | 10,000 | 10,000 | 0 | $39.9K | $97.6K | 0.06% | +$57.7K |
| DocGo Inc.(DCGO) | 764,062 | 49,908 | -714,154 | $1.04M | $43.8K | 0.03% | -$995.3K |
| Zentalis Pharmaceuticals, Inc.(ZNTL) | 17,000 | 17,000 | 0 | $25.7K | $22.9K | 0.01% | -$2.7K |
| Applied Therapeutics Inc | 225,000 | 0 | -225,000 | $136.1K | $0 | — | -$136.1K |
| Avalo Therapeutics, Inc.(AVTX) | 31,000 | 0 | -31,000 | $394.0K | $0 | — | -$394.0K |
| Axogen, Inc.(AXGN) | 119,078 | 0 | -119,078 | $2.12M | $0 | — | -$2.12M |
| Guardant Health, Inc.(GH) | 6,000 | 0 | -6,000 | $374.9K | $0 | — | -$374.9K |
| Healthcare Select Sector Spdr FundSBI HEALTHCARE ST STR CARE ETF | 1,498 | 0 | -1,498 | $208.5K | $0 | — | -$208.5K |
| InflaRx N.V.(IFRX) | 50,000 | 0 | -50,000 | $67.0K | $0 | — | -$67.0K |
| Karyopharm Therapeutics Inc.(KPTI) | 27,985 | 0 | -27,985 | $183.0K | $0 | — | -$183.0K |
| Kiniksa Pharmaceuticals Ltd | 30,000 | 0 | -30,000 | $1.16M | $0 | — | -$1.16M |
| OrthoPediatrics Corp.(KIDS) | 16,000 | 0 | -16,000 | $296.5K | $0 | — | -$296.5K |
| Scholar Rock Holding Corporation(SRRK) | 26,000 | 0 | -26,000 | $968.2K | $0 | — | -$968.2K |
| TELA Bio, Inc.(TELA) | 155,000 | 0 | -155,000 | $230.9K | $0 | — | -$230.9K |
| Zenas BioPharma, Inc.(ZBIO) | 16,500 | 0 | -16,500 | $366.3K | $0 | — | -$366.3K |